Hepatitis B trials in Australia
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study to Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test
- Where
- Melbourne
- Age
- 18 years and over
- People
- 500
- Run by
- bioLytical Laboratories
See details and how to joinNCT07569913 - Phase 2Taking peoplePhase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
- Where
- Fitzroy
- Age
- 18 years to 65 years
- People
- 84 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07370207 - Phase 1Taking peopleA Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
- Where
- Concord, Fortitude Valley
- Age
- 18 years and over
- People
- 48 worldwide
- Run by
- GigaGen, Inc.
See details and how to joinNCT07024641 - No phaseTaking peopleReal World Assessment of People Living With Chronic Hepatitis B in Australia
- Where
- Adelaide, Albany, Birtinya, Broome, Cairns, Darwin, Kalgoorlie-Boulder, Melbourne, Sydney
- Age
- 18 years and over
- People
- 10,000
- Run by
- Kirby Institute
See details and how to joinNCT04914611 - Phase 1/2Not yet taking people in AustraliaA Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection
- Where
- Adelaide
- Age
- 18 years and over
- People
- 40
- Run by
- Vaxine Pty Ltd
See details and how to joinNCT03038802 - No phaseTaking peopleLong-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729)
- Where
- Melbourne, Murdoch
- Age
- 20 years to 70 years
- People
- 50 worldwide
- Run by
- Arbutus Biopharma Corporation
See details and how to joinNCT06277037 - Phase 1Not yet taking people in AustraliaStudy of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients
- Where
- Westmead
- Age
- 18 years to 65 years
- People
- 36 worldwide
- Run by
- Epigenic Therapeutics, Inc
See details and how to joinNCT06661148